CClinicalTrials.gg
CompletedNCT07393230BOD-VASCUpdated Feb 6, 2026

Changes in Orbital Macrovascular and Intraocular Microvascular Blood Flow After Orbital Decompression Surgery in Patients With Thyroid Eye Disease

An interventional study of Balanced Orbital Decompression Surgery in Thyroid Associated Orbitopathy, sponsored by Marmara University Pendik Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-06.

Sponsored by Marmara University Pendik Training and Research Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Apr 2023, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study aims to evaluate the effects of balanced orbital decompression surgery in patients with inactive thyroid-associated orbitopathy. The study examines how the surgery influences blood flow in the orbit and microcirculation in the retina and choroid over time. Clinical findings, imaging results, and vascular changes before and after surgery will be analyzed to better understand the anatomical and functional outcomes of the procedure.

Read the detailed description

Thyroid-associated orbitopathy (TAO) is an autoimmune condition that can lead to increased orbital tissue volume, proptosis, elevated intraocular pressure, and impaired venous outflow. In the inactive phase of the disease, balanced orbital decompression (BOD) is commonly performed to relieve orbital pressure and improve both anatomical and functional outcomes.

While the clinical benefits of orbital decompression are well established, its effects on orbital blood flow and intraocular microcirculation have not been sufficiently investigated, particularly over time. This study is designed to prospectively evaluate the impact of BOD on orbital macrovascular structures and retinal-choroidal microvascular networks in patients with inactive TAO.

Patients undergoing BOD for severe proptosis will be evaluated before surgery and at multiple postoperative follow-up visits. Assessments include clinical ophthalmologic examinations, intraocular pressure measurements, and imaging-based evaluation of orbital and intraocular circulation. Orbital macrovascular parameters will be assessed using Doppler ultrasonography, while retinal and choroidal microcirculation will be analyzed using optical coherence tomography angiography (OCTA).

The study aims to characterize time-dependent vascular changes following surgery and to explore the relationship between macrovascular and microvascular responses. By providing longitudinal data, this study seeks to improve understanding of how orbital decompression influences ocular perfusion and vascular regulation, contributing to a more comprehensive evaluation of surgical outcomes in inactive TAO.

02

Conditions studied

  • Thyroid Associated Orbitopathy

Keywords

  • Thyroid-Associated Orbitopathy
  • Balanced Orbital Decompression
  • Orbital Blood Flow
  • Retinal and Choroidal Microcirculation
  • OCT Angiography
  • Doppler Ultrasonography
03

In context

Lead sponsor

Marmara University Pendik Training and Research Hospital is the lead sponsor of 32 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 18 years or older
  • Diagnosis of inactive thyroid-associated orbitopathy
  • Presence of moderate-to-severe proptosis with indication for surgical orbital decompression
  • Planned to undergo balanced orbital decompression surgery
  • Ability to provide written informed consent
  • Adequate image quality for OCTA and Doppler ultrasonography assessments

Exclusion criteria

Exclusion Criteria:

  • Active phase thyroid-associated orbitopathy
  • Thyroid dysfunction or systemic condition contraindicating general anesthesia
  • Proptosis due to causes other than TAO
  • History of orbital radiotherapy
  • Previous orbital or intraocular surgery
  • Presence of retinal or choroidal pathology affecting vascular measurements
  • History of systemic vasculitis or other vascular diseases
  • Diabetes mellitus or systemic hypertension
  • Use of systemic immunosuppressive therapy
  • Age under 18 years
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Balanced Orbital Decompression Surgery

    Participants in this arm undergo balanced orbital decompression surgery performed for inactive thyroid-associated orbitopathy, with preoperative and postoperative clinical and vascular assessments.

    Procedure: Balanced Orbital Decompression Surgery

Interventions

  • ProcedureBalanced Orbital Decompression Surgery

    Balanced orbital decompression is performed under general anesthesia using a combined medial and lateral orbital wall approach with orbital fat removal, aiming to reduce orbital pressure and improve orbital and ocular circulation in patients with inactive thyroid-associated orbitopathy.

    Also known as: Combined medial and lateral orbital wall decompression with orbital fat excision

06

What researchers measure

Primary outcomes

  1. Change in ophthalmic artery flow velocities

    Change in peak systolic velocity and end-diastolic velocity of the ophthalmic artery, measured in cm/s, assessed by color Doppler ultrasonography before and after surgery.

    Time frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months

  2. Change in central retinal artery flow velocities

    Change in peak systolic velocity and end-diastolic velocity of the central retinal artery, measured in cm/s, assessed by color Doppler ultrasonography before and after surgery.

    Time frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months

  3. Change in superior ophthalmic vein diameter

    Change in superior ophthalmic vein diameter, measured in millimeters (mm), assessed by magnetic resonance imaging before and after surgery.

    Time frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months

Secondary outcomes

  1. Change in superficial capillary plexus vessel density

    Change in vessel density of the superficial capillary plexus, expressed as a percentage (%), assessed by optical coherence tomography angiography before and after surgery.

    Time frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months

  2. Change in deep capillary plexus vessel density

    Change in vessel density of the deep capillary plexus, expressed as a percentage (%), assessed by optical coherence tomography angiography before and after surgery.

    Time frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months

  3. Change in choriocapillaris vessel density

    Change in vessel density of the choriocapillaris, expressed as a percentage (%), assessed by optical coherence tomography angiography before and after surgery.

    Time frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months

  4. Change in choroidal vascularity index

    Change in choroidal vascularity index (unitless), assessed by optical coherence tomography before and after surgery.

    Time frame: Baseline and postoperative follow-up visits at 1, 3, and 6 months

07

Study locations

1 site
  • Marmara University School of Medicine, Department of Ophthalmology
    Istanbul, Pendik 34899, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07393230
Lead sponsor
Marmara University Pendik Training and Research Hospital
Responsible party
Burçin Göğüş Çamlı (Ophthalmologist, Department of Ophthalmology, Marmara University School of Medicine, Marmara University Pendik Training and Research Hospital) — Principal investigator
First posted
Feb 6, 2026
Start date
Apr 4, 2023
Primary completion
Apr 30, 2024
Completion
May 25, 2024
Last update
Feb 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion